Back to results
US 6,720,409 B2Granted
Anti-human influenza virus antibody
AssigneeTakara Shuzo Co., Ltd.
InventorsYoshinobu Okuno, Yuji Isegawa, Fuyoko Sasao, Shigeharu Ueda
Life of this patent
Estimating the term…
Loading patent…
Loading patent…
AssigneeTakara Shuzo Co., Ltd.
InventorsYoshinobu Okuno, Yuji Isegawa, Fuyoko Sasao, Shigeharu Ueda
Estimating the term…
[Object] To provide an anti-human influenza virus antibody and an immunogenic artificial polypeptide. [Constitution] An anti-human influenza virus antibody which recognizes the stem regions of haemagglutinin molecules of the H1N1 and H2N2 subtypes and has a neutralization activity but does not recognize the stem region of the H3N2 subtype and has no neutralization activity. An immunogenic artificial polypeptide having an antigenicity substantially same as the stem regions of haemagglutinin molecules. An immunogenic artificial polypeptide having an antigenicity substantially same as the stem regions of haemagglutinin molecule and lacking the globular head region of haemagglutinin molecules. [Effect] This antibody is useful in the diagnosis and treatment of influenza A virus, while these polypeptides are useful as a vaccine.
An isolated gene which codes for a polypeptide having an antigenicity which is the same as that of the stem region of hemagglutinin molecule of human influenza A virus, wherein said gene encodes the amino acid sequence of SEQ ID No. 46.
An isolated gene which codes for a polypeptide having an antigenicity which is the same as that of the stem region of hemagglutinin molecule of human influenza A virus and lacking a globular head region of hemagglutinin molecule of human influenza A virus, wherein said gene encodes the amino acid sequence of SEQ ID No. 50 or the amino acid sequence of SEQ ID No. 58.
Dependencies are inferred from the claim text.